Your browser doesn't support javascript.
loading
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome.
Meuleman, Marie-Sophie; Guilmin-Crépon, Sophie; Hummel, Aurélie; Daugas, Eric; Dumas, Agnès; Leye, Fallou; Dantal, Jacques; Rigothier, Claire; Provot, François; Chauveau, Dominique; Burtey, Stéphane; Hertig, Alexandre; Dahan, Karine; Durrbach, Antoine; Dossier, Claire; Karras, Alexandre; Guerrot, Dominique; Esnault, Vincent; Rémy, Philippe; Massy, Ziad A; Tostivint, Isabelle; Morin, Marie-Pascale; Zaoui, Philippe; Fritz, Olivier; Le Quintrec, Moglie; Wynckel, Alain; Bourmaud, Aurélie; Boyer, Olivia; Sahali, Dil; Alberti, Corinne; Audard, Vincent; Mellerio, Hélène.
  • Meuleman MS; Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marecha
  • Guilmin-Crépon S; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris Est Créteil, Equipe 21, Creteil, France. marie.meuleman@aphp.fr.
  • Hummel A; Université de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
  • Daugas E; Unité d'Épidémiologie Clinique, CIC 1426, AP-HP.Nord, Hôpital Universitaire Robert Debré, Inserm, 75019, Paris, France.
  • Dumas A; Service de Néphrologie, AP-HP, Hôpital Necker, Paris, France.
  • Leye F; Service de Néphrologie, AP-HP, Hôpital Bichat, Université de Paris, INSERM U1149, Paris, France.
  • Dantal J; Université de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
  • Rigothier C; Unité d'Épidémiologie Clinique, CIC 1426, AP-HP.Nord, Hôpital Universitaire Robert Debré, Inserm, 75019, Paris, France.
  • Provot F; Service de Néphrologie Immunologie Clinique Transplantation, Centre de Recherche en Transplantation et Immunologie (CRTI), Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France.
  • Chauveau D; Service de Néphrologie Transplantation, Dialyse et Aphérèses, CHU de Bordeaux, Bordeaux, France.
  • Burtey S; Service de Néphrologie, Hôpital Huriez, CHU de Lille, Lille, France.
  • Hertig A; Service de Néphrologie et Transplantation d'Organes, Hôpital de Rangueil et Centre de Référence Maladies Rénales Rares, CHU de Toulouse, Toulouse, France.
  • Dahan K; APHM, INSERM, INRAe, C2VN, Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Aix Marseille University, Marseille, France.
  • Durrbach A; Service de Néphrologie et Transplantation Rénale, AP-HP, Hôpital Tenon, Paris, France.
  • Dossier C; Service de Néphrologie et Dialyse, AP-HP, Hôpital Tenon, Paris, France.
  • Karras A; Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marecha
  • Guerrot D; Service de Néphrologie Pédiatrique, AP-HP, Hôpital Robert Debré, Paris, France.
  • Esnault V; Service de Néphrologie, AP-HP, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France.
  • Rémy P; Service de Néphrologie, CHU de Rouen, Rouen, France.
  • Massy ZA; Service de Néphrologie, Hôpital Pasteur, CHU de Nice, Nice, France.
  • Tostivint I; Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marecha
  • Morin MP; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris Est Créteil, Equipe 21, Creteil, France.
  • Zaoui P; Service de Néphrologie, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
  • Fritz O; INSERM U1018 CESP, UVSQ, UPS Villejuif, Villejuif, France.
  • Le Quintrec M; Service de Néphrologie et Transplantation, AP-HP, Hôpital Pitié Salpêtrière, Paris, France.
  • Wynckel A; Service de Néphrologie, Hôpital de Pontchaillou, CHU de Rennes, Rennes, France.
  • Bourmaud A; Service de Néphrologie, Hémodialyse, Aphérèse et Transplantation Rénale, CHU de Grenoble Alpes, Université Grenoble-Alpes, Grenoble, France.
  • Boyer O; Service de Néphrologie, Centre Hospitalier (CH) La Rochelle, La Rochelle, France.
  • Sahali D; Service de Néphrologie Dialyse et Transplantation Rénale, Hôpital Lapeyronie, CHU de Montpellier, Montpellier, France.
  • Alberti C; Service de Néphrologie, CHU de Reims, Reims, France.
  • Audard V; Université de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
  • Mellerio H; Unité d'Épidémiologie Clinique, CIC 1426, AP-HP.Nord, Hôpital Universitaire Robert Debré, Inserm, 75019, Paris, France.
J Nephrol ; 35(4): 1123-1134, 2022 05.
Article en En | MEDLINE | ID: mdl-34224090
BACKGROUND: Long-term psychosocial outcomes and health-related quality of life (HRQOL) in adults with pediatric onset of frequently relapsing or steroid-dependent idiopathic nephrotic syndrome (FRNS or SDNS) remain to be determined. METHODS: In this prospective cohort study, 59 adults with pediatric onset of FRNS/SDNS and persistent active glomerular disease in adulthood completed the GEDEPAC-2 questionnaire exploring 11 well-being domains. Data were compared to the French general population (FGP) with standardized incidence ratio ([SIR]; adjusted for period, age, gender). Regression models were performed to identify predictive factors of psychosocial well-being. RESULTS: In 82% of cases, the questionnaire was completed while the participants (n = 59; 47 men; median age = 32 years; median number of relapses = 13) were in complete remission (under specific therapy in 76% of cases). Participants had higher educational degree than in the FGP (SIR = 6.3; p < 0.01) and more frequently a managerial occupation (SIR = 3.1; p < 0.01). Social integration was acceptable with regard to marital status and experience of sexual intercourse, but experiences of discrimination were far more frequent (SIR = 12.5; p < 0.01). The SF-12 mental component summary (MCS) score was altered (Z-score = - 0.6; p < 0.01) and mean multidimensional fatigue inventory (MFI-20) global fatigue score appeared high (12). Transfer from pediatric to adult healthcare was followed by a period of discontinued care for 33% of participants. Multivariate analysis revealed a close relationship between MFI-20, physical health, and MCS. CONCLUSIONS: This study shows that pediatric onset FRNS and SDNS may have a long-term negative impact on mental HRQOL and highlights the impact of fatigue, which is often not adequately considered in routine care.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Nefrótico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Nefrótico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article